Back to Resources

Q2 2026 CAR-T Therapies Market Premieres New Study Data and Campaigns

Market Highlights

  • Bristol Myers Squibb presented new study results for Breyanzi.

  • Gilead announced its purchase of Arcellx and launched a Yescarta campaign.

  • Legend Biotech showcased trial results and launched a new theme for Carvkyti.

  • Novartis touted an expansion of programs.

Questions about this SnapShot or other markets?

U.S. MARKETS

Christine Alongi
alongi@dtwresearch.com

GLOBAL MARKETS

Robin Cefalo
cefalo@dtwresearch.com

SOCIAL MEDIA MARKETS

Andrew Carney
carney@dtwresearch.com

Get in Touch

Want to see what we can do for your organization? We’ll walk you through CDP, train your team, and stay close with ongoing support.

Contact us